Psychiatry’s Continuing Expansion of Depressive Disorder

History, Philosophy and Theory of the Life Sciences

Volumn 15, Issue , 2016, Pages 173-203

  Wakefield, Jerome C ^a   Horwitz, Allan V ^b  

^a NEW YORK UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Bereavement exclusion; Diagnosis; DSM 5; False positive diagnosis; Grief; Harmful dysfunction; Major depression; Psychiatric epidemiology; Sadness

Indexed keywords

EID: 85020083134     PISSN: 22111948     EISSN: 22111956     Source Type: Book Series    
DOI: 10.1007/978-94-017-7423-9_12     Document Type: Chapter

References (127)

1. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.: DSM-III). Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed., text revision; DSM-IV-TR). Washington, DC: American Psychiatric Association.
3. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.: DSM-5). Arlington: American Psychiatric Association.
4. Andrews, P. W., & Thomson, J. A., Jr. (2009). The bright side of being blue: Depression as an adaptation for analyzing complex problems. Psychological Review, 116(3), 620–654.
5. Angell, M. (2011a). The epidemic of mental illness: Why? New York Review of Books, June 23, 2011. http://www.nybooks.com/articles/archives/2011/jun/23/epidemic-mental-illness-why. Accessed 6 April 2014.
6. Angell, M. (2011b). The illusions of psychiatry. New York Review of Books, July 14, 2011. http://www.nybooks.com/articles/archives/2011/jul/14/illusions-of-psychiatry. Accessed 6 April 2014.
7. Axelson, D., Findling, R. L., Fristad, M. A., Kowatch, R. A., Youngstrom, E. A., Horwitz, S. M., et al. (2012). Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms Study. Journal of Clinical Psychiatry, 73(10), 1342–1350.
8. Blanchflower, D. G., & Oswald, A. J. (2011). Antidepressants and age. Institute for the Study of Labor (IZA), Bonn. http://ftp.iza.org/dp5785.pdf. Accessed 6 April 2014.
9. Brooks, M. (2012, February 16). Lancet weighs in on DSM-5 Bereavement exclusion. Medscape. http://www.medscape.com/viewarticle/758788. Accessed 6 April 2014.
10. Clayton, P. J. (1982). Bereavement. In E. S. Paykel (Ed.), Handbook of affective disorders (pp. 15–46). London: Churchill Livingstone.
11. Clayton, P. J., Desmarais, L., & Winokur, G. (1968). A study of normal bereavement. American Journal of Psychiatry, 125, 168–178.
12. Clayton, P. J., Halikas, J. A., & Maurice, W. L. (1972). The depression of widowhood. British Journal of Psychiatry, 120, 71–78.
13. Corruble, E., Chouinard, V. A., Letierce, A., et al. (2009). Is DSM-IV bereavement exclusion for major depressive episode relevant to severity and pattern of symptoms? A case control, cross-sectional study. Journal of Clinical Psychiatry, 70, 1091–1097.
14. Coryell, W. (2012, April 17). Proposal to eliminate bereavement exclusion criteria from major depressive episode in DSM-5. DSM5ORG, Major depressive Episode, Rationale . http://www. dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=427. Accessed 5 May 2012.
15. Eaton, W. W., Badawi, M., & Melton, B. (1995). Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry, 152, 967–972.
16. Editorial. (2012). Living with grief. Lancet, 379, 589.
17. European Medicines Agency. (2011). Guideline on the treatment of premenstrual dysphoric disorder (PMDD). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guide-line/2011/08/WC500110103.pdf. Accessed 4 May 2013.
18. Fawcett, J. (2010). An overview of mood disorders in the DSM-5. Current Psychiatry Report, 12, 531–538.
19. First, M. B., & Wakefield, J. C. (2013). Diagnostic criteria as dysfunction indicators: Bridging the chasm between the definition of mental disorder and diagnostic criteria for specific disorders. Canadian Journal of Psychiatry, 58(12), 663–669.
20. Frances, A. (2013a, April 25). The international reaction to DSM 5. Psychology Today Blog. http://www.psychologytoday.com/blog/saving-normal/201304/the-international-reaction-dsm-5. Accessed 5 April 2014.
21. Frances, A. (2013b). Saving normal. New York: William Morrow.
22. Friedman, R. A. (2012). Grief, depression, and the DSM-5. New England Journal of Medicine, 366, 1855–1857.
23. Gili, M., Roca, M., Stuckler, D., Basu, S., & McKee, M. (2013). 2255-The mental health risks of economic crisis in Spain: Evidence from primary care centres, 2006 and 2010. European Psychiatry, 28(Suppl 1), 1.
24. Gilman, S. E., Breslau, J., Trinh, N. H., Fava, M., Murphy, J. M., & Smoller, J. W. (2012). Bereavement and the diagnosis of major depressive episode in the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 73, 208–215.
25. Goldberg, D. (2011). The heterogeneity of “major depression”. World Psychiatry, 10, 226–228.
26. Greenberg, G. (2013). The book of Woe: The DSM and the unmaking of psychiatry. New York: Blue Rider Press.
27. Gueorguieva, R., Mallinckrodt, C., & Krystal, J. H. (2011). Trajectories of depression severity in clinical trials of duloxetine: Insights into antidepressant and placebo responses. Archives of General Psychiatry, 68(12), 1227–1237.
28. Haddad, P. M. (2001). Antidepressant discontinuation syndromes. Drug Safety, 24(3), 183–197.
29. Haddad, P. M., & Anderson, I. M. (2007). Recognising and managing antidepressant discontinuation symptoms. Advances in Psychiatric Treatment, 13, 447–457.
30. Halbreich, U. (2004). The diagnosis of premenstrual syndromes and premenstrual dysphoric dis-order–clinical procedures and research perspectives. Gynecological Endocrinology, 19(6), 320–334.
31. Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003). The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology, 28(3), 1–23.
32. Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). The epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 62, 1097–1106.
33. Hollingworth, S., et al. (2010). Affective and anxiety disorders: Prevalence, treatment and antidepressant medication use. Australian and New Zealand Journal of Psychiatry, 44, 513–519.
34. Horgan, J. (2011, July 12). Are Antidepressants Just Placebos with Side Effects? CrossCheck, Scientific American Blog Network. http://blogs.scientificamerican.com/cross-check/2011/07/12/are-antidepressants-just-placebos-with-side-effects/. Accessed 6 April 2014.
35. Horwitz, A. V., & Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
36. Horwitz, A. V., & Wakefield, J. C. (2010). Tristesse ou depression? Comment la psychiatrie a medicalise nos tristesses. Traduit de l’anglais par Francoise Parot. Wavre: Edition Mardaga.
37. Kendler, K. S. (2010). Statement on the proposal to eliminate the grief exclusion criterion from major depression. http://www.dsm5.org/. Accessed 16 October 2010.
38. Kendler, K. S., Myers, J., & Zisook, S. (2008). Does bereavement related major depression differ from major depression associated with other stressful life events? American Journal of Psychiatry, 165, 1449–1455.
39. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Eshelman, S., Wittchen, H. U., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
40. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M. S., & Blazer, D. G. (1996). Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. British Journal of Psychiatry, 168(suppl. 30), 17–30.
41. Kessler, R. C., Beglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey replication. Journal of the American Medical Association, 289, 3095–3105.
42. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 62, 593–602.
43. Kirsch, I. (2010). The emperor’s new drugs: Exploding the antidepressant myth. New York: Basic Books.
44. Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002). The emperor’s new drugs: An analysis of antidepressant medication data. Prevention and Treatment, 5, 23. doi:10.1037/1522-3736.5.1.523a.
45. Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), e45. doi:10.1371/journal.pmed.0050045.
46. Kitanaka, J. (2016). Depression as a problem of labor: Japanese debates about work, stress, and a new therapeutic ethos. In J. C. Wakefield & S. Demazeux (Eds.), Sadness or depression? International perspectives on the depression epidemic and its meaning. Dordrecht: Springer.
47. Klein, D. F., & Thase, M. (1997). Medication versus psychotherapy for depression: Progress notes. American Society of Clinical Psychopharmacology, 8, 41–47.
48. Kleinman, A. (2012). Culture, bereavement and psychiatry. Lancet, 379, 608–609.
49. Kramer, P. D. (2011, July 9). In defense of antidepressants. New York Times Sunday Review. http://www.nytimes.com/2011/07/10/opinion/sunday/10antidepressants.html?pagewanted=all. Accessed 25 July 2011.
50. Kruijshaar, M. E., Barendregt, J., Vos, T., de Graaf, R., Spijker, J., & Andrews, G. (2005). Lifetime prevalence estimates of major depression: An indirect estimate and a quantification of recall bias. European Journal of Epidemiology, 20, 103–111.
51. Lamb, K., Pies, R., & Zisook, S. (2010). The bereavement exclusion for the diagnosis of major depression: To be or not to be. Psychiatry, 7, 19–25.
52. Lane, C. 2011. Antidepressant withdrawal syndrome: Why SSRI antidepressants often produce a withdrawal syndrome. Psychology Today Blog. http://www.psychologytoday.com/blog/side-effects/201107/antidepressant-withdrawal-syndrome. Accessed 20 March 2014.
53. Maj, M. (2011a). When does depression become a mental disorder? British Journal of Psychiatry, 199, 85–86.
54. Maj, M. (2011b). Refining the diagnostic criteria for major depression on the basis of empirical evidence. Acta Psychiatrica Scandinavica, 123, 317.
55. Maj, M. (2013). “Clinical judgment” and the DSM-5 diagnosis of major depression. World Psychiatry, 12(2), 89–91.
56. Marcus, S. C., & Olfson, M. (2010). National trends in the treatment for depression from 1998 to 2007. Archives of General Psychiatry, 67(12), 1265–1273.
57. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3, e442. doi:10.1371/journal.pmed.0030442.
58. Melander, H., et al. (2008). A regulatory Apologia – A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. European Neuropsychopharmacology, 18(9), 623–627.
59. Mercier, A., Auger-Aubin, I., Lebeau, J.-P., Van Royen, P., & Peremans, L. (2011). Understanding the prescription of antidepressants: A qualitative study among French GPs. BMC Family Practice, 12(99), 1–9. http://www.biomedcentral.com/1471-2296/12/99.
60. Mitchell, A. J., Vaze, S., & Rao, S. (2009). Clinical diagnosis of depression in primary care: A metaanalysis. Lancet, 374, 609–619.
61. Moffitt, T. E., Harrington, H. L., Caspi, A., Kim-Cohen, J., Goldberg, D., Gregory, A. M., & Poulton, R. (2007). Depression and generalized anxiety disorder: Cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Archives of General Psychiatry, 64, 651–660.
62. Moffitt, T. E., Caspi, A., Taylor, A., Kokaua, J., Milne, B., Polanczyk, G., & Poulton, R. (2010). How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine, 40(6), 899–909.
63. Mojtabai, R. (2008). Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychotherapy and Psychosomatics, 77(2), 83–92.
64. Mojtabai, R. (2011). Bereavement-related depressive episodes: Characteristics, 3-year course, and implications for DSM-5. Archives of General Psychiatry, 68, 920–928.
65. Mojtabai, R. (2013). Clinician-identified depression in community settings: Concordance with structured-interview diagnoses. Psychotherapy and Psychosomatics, 82, 161–169.
66. Mojtabai, R., & Olfson, M. (2011). Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Affairs, 30(8), 1434–1442. doi:10.1377/hlthaff.2010.1024.
67. Moncrieff, J., Wessely, S. & Hardy, R. (2004). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, 2004(1):CD003012.
68. Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009). Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. British Medical Journal, 339, 1–7. doi:10.1136/bmj.b3999.
69. Narrow, W. E., Rae, D. S., Robin, L. N., & Regier, D. A. (2002). Revised prevalence estimates of mental disorder in the United States: Using a clinical significance criterion to reconcile 2 sur-vey’s estimates. Archives of General Psychiatry, 59, 115–123.
70. OECD. (2013). Health at a glance 2013: OECD indicators. OECD Publishing. http://dx.doi. org/10.1787/health_glance-2013-en
71. Oldham, J., Carlat, D., Friedman, R., et al. (2011, August 18). ‘The illusions of psychiatry’: An exchange. New York Review of Books. http://www.nybooks.com/articles/archives/2011/aug/18/illusions-psychiatry-exchange. Accessed 6 April 2014.
72. Olfson, M., Marcus, S. C., Druss, B., & Pincus, H. A. (2002). National trends in the use of outpatient psychotherapy. American Journal of Psychiatry, 159, 1914–1920.
73. Parker, G. (1979). Sex differences in non-clinical depression. Australian and New Zealand Journal of Psychiatry, 13, 127–132.
74. Parker, G. (2007). Is depression overdiagnosed? Yes. BMJ, 335(7615), 328. doi:10.1136/bmj.39268.475799.AD.
75. Parker, G. (2011). Classifying clinical depression: An operational proposal. Acta Psychiatrica Scandinavica, 123, 314–316.
76. Parkes, C. (1964). Recent bereavement as a cause of mental illness. British Journal of Psychiatry, 110, 198–204.
77. Pies, R. (2008, December 12). Major depression after recent loss is major depression – Until proved otherwise. Psychiatric Times, p. 12.
78. Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010). Efficacy and effectiveness of antidepressants: Current status of research. Psychotherapy and Psychosomatics, 79(5), 267– 279. doi:10.1159/000318293. Epub 2010 Jul 9.
79. Pratt, L. A., Brody, D. J., & Gu, Q. (2011). Antidepressant use in persons aged 12 and over: United States, 2005–2008 (NCHS data brief, no 76). Hyattsville: National Center for Health Statistics.
80. Prigerson, H. G., Horowitz, M. J., Jacobs, S. C., Parkes, C. M., Aslan, M., Goodkin, K., et al. (2009). Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11. PLoS Medicine, 6, e1000121.
81. Read, J., Cartwright, C., & Gibson, K. (2014). Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research, 216, 67–73.
82. Regier, D. A., Kaelber, C. T., Rae, D. S., Farmer, M. E., Knauper, B., Kessler, R. C., et al. (1998). Limitations of diagnostic criteria and assessment instruments for mental disorders: Implications for research and policy. Archives of General Psychiatry, 55, 109–115.
83. Robins, L. N., & Regier, D. A. (1991). Psychiatric disorders in America. New York: Free Press.
84. Rohde, P., Lewinsohn, P. M., Klein, D. N., Seeley, J. R., & Gau, J. M. (2013). Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clinical Psychological Science, 1 (1), 41–53.
85. Schatzberg, A. F., Blier, P., Delgado, P. L., Fava, M., Haddad, P. M., & Shelton, R. C. (2006). Antidepressant discontinuation syndrome: Consensus panel recommendations for clinical management and additional research. Journal of Clinical Psychiatry, 67(Suppl 4), 27–30.
86. Shear, M., Katherine, N., Simon, M., Wall, S., Zisook, R., Neimeyer, N. D., et al. (2011). Complicated grief and related bereavement issues for DSM-5. Depression and Anxiety, 28, 103–117.
87. Spitzer, R. L., & Wakefield, J. C. (1999). DSM-IV diagnostic criterion for clinical significance: Does it help solve the false positives problem? American Journal of Psychiatry, 156, 1856–1864.
88. Stewart, J. A., Deliyannides, D. A., Hellerstein, D. J., McGrath, P. J., & Stewart, J. W. (2012). Can people with nonsevere major depression benefit from antidepressant medication? Journal of Clinical Psychiatry, 73(4), 518–525.
89. Sunday dialogue: seeking a path through depression’s landscape. (2011, July 16). New York Times Sunday Review. http://www.nytimes.com/2011/07/17/opinion/sunday/l17dialogue. html?pagewanted=all. Accessed 5 August 2011.
90. Thase, M. E., Larsen, K. G., & Kennedy, S. H. (2011). Assessing the ‘true’ effect of active antidepressant therapy v. placebo in major depressive disorder: Use of a mixture model. British Journal of Psychiatry, 199, 501–507.
91. Tyrer, P. (2009). Are general practitioners really unable to diagnose depression? Lancet, 374, 589–590.
92. Ustun, T. B., Yuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 386–392.
93. Wakefield, J. C. (1992). The concept of mental disorder: On the boundary between biological facts and social values. American Psychologist, 4, 373–388.
94. Wakefield, J. C. (2006). The concept of mental disorder: Diagnostic implications of the harmful dysfunction analysis. World Psychiatry, 6, 149–156.
95. Wakefield, J. C. (2009). Disability and diagnosis: Should role impairment be eliminated from DSM/ICD diagnostic criteria? World Psychiatry, 8, 87–88.
96. Wakefield, J. C. (2011). Should uncomplicated bereavement-related depression be reclassified as a disorder in DSM-5? Response to Kenneth S. Kendler’s statement defending the proposal to eliminate the bereavement exclusion. Journal of Nervous and Mental Disease, 199, 203–208.
97. Wakefield, J. C. (2012). Should prolonged grief be reclassified as a mental disorder in DSM-5? Reconsidering the empirical and conceptual arguments for proposed grief disorders. Journal of Nervous and Mental Disease, 200, 499–511.
98. Wakefield, J. C. (2013a). The DSM-5 debate over the bereavement exclusion: Psychiatric diagnosis and the future of empirically supported practice. Clinical Psychology Review, 33, 825–845.
99. Wakefield, J. C. (2013b). Is complicated/prolonged grief a disorder? Why the proposal to add “complicated grief disorder” to the DSM-5 is conceptually and empirically unsound. In M. Stroebe, H. Schut, & J. van den Bout (Eds.), Complicated grief: Scientific foundations for health care professionals (pp. 99–114). New York: Routledge.
100. Wakefield, J. C., & First, M. B. (2012a). Does the empirical evidence support the proposal to eliminate the major depression “bereavement exclusion” in DSM-5? World Psychiatry, 11, 3–10.
101. Wakefield, J. C., & First, M. B. (2012b). Placing symptoms in context: The role of contextual criteria in reducing false positives in DSM diagnosis. Comprehensive Psychiatry, 53, 130–139.
102. Wakefield, J. C., & First, M. B. (2013). The importance and limits of harm in identifying mental disorder. Canadian Journal of Psychiatry, 58 (11), 618–621.
103. Wakefield, J. C., & Schmitz, M. F. (2012a). Recurrence of depression after bereavement-related depression: Evidence for the validity of the DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. Journal of Nervous and Mental Disease, 200, 480–485.
104. Wakefi eld, J. C., & Schmitz, M. F. (2012b). Beyond reactive versus endogenous: Should uncomplicated stress-triggered depression be excluded from major depression diagnosis? A review of the evidence. Minerva Psichiatrica, 53, 251–276.
105. Wakefield, J. C., & Schmitz, M. F. (2013a). Normal vs. disordered bereavement-related depression: Are the differences real or tautological? Acta Psychiatrica Scandinavica, 127, 159–168.
106. Wakefield, J. C., & Schmitz, M. F. (2013b). Can the DSM’s major depression bereavement exclusion be validly extended to other stressors?: Evidence from the NCS. Acta Psychiatrica Scandinavica, 128, 294–305.
107. Wakefield, J. C., & Schmitz, M. F. (2013c). When does depression become a disorder? Using recurrence rates to evaluate the validity of proposed changes in major depression diagnostic thresholds. World Psychiatry, 12, 44–52.
108. Wakefield, J. C., & Schmitz, M. F. (2014a). Uncomplicated depression, suicide attempt, and the DSM-5 bereavement-exclusion debate: An empirical evaluation. Research on Social Work Practice, 24(1), 37–49.
109. Wakefield, J. C., & Schmitz, M. F. (2014b). Predictive validation of single episode uncomplicated depression as a benign subtype of unipolar major depression. Acta Psychiatrica Scandinavica, 129, 445–457.
110. Wakefi eld, J. C., & Spitzer, R. L. (2002). Lowered estimates – But of what? Archives of General Psychiatry, 59, 129–130.
111. Wakefield, J. C., Schmitz, M. F., First, M. B., & Horwitz, A. V. (2007). Should the bereavement exclusion for major depression be extended to other losses? Evidence from the National Comorbidity Survey. Archives of General Psychiatry, 64, 433–440.
112. Wakefield, J. C., Schmitz, M. F., & Baer, J. C. (2010). Does the DSM-IV clinical significance criterion for major depression reduce false positives?: Evidence from the NCS-R. The American Journal of Psychiatry, 167, 298–304.
113. Wakefield, J. C., Schmitz, M. F., & Baer, J. C. (2011a). Relation between duration and severity in bereavement-related depression. Acta Psychiatrica Scandinavica, 124, 487–494.
114. Wakefield, J. C., Schmitz, M. F., & Baer, J. C. (2011b). Did narrowing the major depression bereavement exclusion from DSM-III-R to DSM-IV increase validity? Evidence from the National Comorbidity Survey. Journal of Nervous and Mental Disease, 199, 66–73.
115. Warner, C. H., Bobo, W., Warner, C., Reid, S., & Rachal, J. (2006). Antidepressant discontinuation syndrome. American Family Physician, 74(3), 449–456.
116. Watters, E. (2010). Crazy like us: The globalization of the American psyche. New York: The Free Press.
117. Weber, C. (2013). Wenn Trauer zur Krankheit wird. Suddeutche Zeitung. http://www.suedde-utsche.de/gesundheit/neue-diagnosekriterien-in-der-psychiatrie-wenn-trauer-zur-krankheit-wird-1.1649873. Accessed 5 April 2014.
118. Wells, J. E., & Horwood, L. J. (2004). How accurate is recall of key symptoms of depression? A comparison of recall and longitudinal reports. Psychological Medicine, 34, 1001–1011.
119. Whoriskey, P. (2012, December 26). Antidepressants to treat grief? Psychiatry panelists with ties to drug industry say yes. The Washington Post. http://www.washingtonpost.com/business/economy/antidepressants-to-treat-grief-psychiatry-panelists-with-ties-to-drug-industry-say-yes/2012/12/26/ca09cde6-3d60-11e2-ae43-cf491b837f7b_story.html. Accessed 6 April 2014.
120. Wilhelm, K., Parker, G., & Hadzi-Pavlovic, D. (1996). Fifteen years on: Evolving ideas in researching sex differences in depression. Psychological Medicine, 27, 875–883.
121. Wilhelm, K., Mitchell, P. B., Niven, H., Finch, A., Wedgwood, L., Scimone, A., Blair, I. P., Parker, G., & Schofield, P. R. (2006). Life events, first depression onset and the serotonin transporter gene. British Journal of Psychiatry, 188, 210–215.
122. World Health Organization. (1992). ICD-10: International statistical classifi cation of diseases and related health problems, tenth revision. Geneva: World Health Organization.
123. Zajecka, J., Tracy, K. A., & Mitchell, S. (1997). Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review. Journal of Clinical Psychiatry, 58, 291–297.
124. Zisook, S.. (2010, August 2). Today in your health: Bereavement. National Public Radio, Morning Edition.
125. Zisook, S., & Kendler, K. S. (2007). Is bereavement-related depression different than nonbereavement-related depression? Psychological Medicine, 37, 779–794.
126. Zisook, S., Shuchter, S. R., Pedrelli, P., Sable, J., & Deaciuc, S. C. (2001). Bupropion sustained release for bereavement: Results of an open trial. Journal of Clinical Psychiatry, 62, 227–230.
127. Zisook, S., Shear, K., & Kendler, K. S. (2007). Validity of the bereavement exclusion criterion for the diagnosis of major depressive episode. World Psychiatry, 6, 102–107.